Latest status of the drug patent law
Banci, F.
Bollettino Chimico Farmaceutico 109(12): 699-701
1970
ISSN/ISBN: 0006-6648 PMID: 5521480 Document Number: 26060
Document emailed within 1 workday
Related Documents
Halliburton, M. 2009: Drug resistance, patent resistance: Indian pharmaceuticals and the impact of a new patent regime Global Public Health 4(6): 515-527Furness, G. 2004: Drug delivery - latest technologies and partnerships Idrugs: the Investigational Drugs Journal 7(2): 133-135
Conti, C.R. 1998: Viagra, the latest cardio-VASCULAR drug Clinical Cardiology 21(9): 616
Sargent, J.A.; Paget, M.; Clevenger, I. 1991: Planned cuts in drug payments latest in trend by HCFA seeking more for less Nephrology News and Issues 5(6): 14-16
Nusbaum, N.J. 1992: Drug development and patent law New York State Journal of Medicine 92(3): 86-87
Carlson, J. 2009: Judge denies nurse class-action status. Chicago ruling latest in victory for hospitals facing antitrust lawsuits Modern Healthcare 39(40): 16
Watson, R. 2010: European Commission targets drug firms over illegal patent protection Bmj 340: C268
Pavento, L.C.; Greene, J.L.; McDonald, J.K. 2003: International patent protection for HIV-related therapies: patent attorney's perspective Emory international law review 17(2): 919-931
Faunce, T. 2015: Australian Competition and Consumer Commission V Pfizer: Evergreening and Market Power as a Blockbuster Drug Goes off Patent Journal of Law and Medicine 22(4): 771-787
Schiff, J. 2016: Patently perturbed. Trans-Pacific Partnership trade deal raises fears about drug patent periods, higher costs Modern Healthcare 46(23): 36-38
Nazrul Islam, S.K.; Jahangir Hossain, K.; Ahsan, M. 2001: Serum vitamin E, C and A status of the drug addicts undergoing detoxification: influence of drug habit, sexual practice and lifestyle factors European Journal of Clinical Nutrition 55(11): 1022-1027
Ahmed, S.Masud.; Naher, N.; Hossain, T.; Rawal, L.Bahadur. 2017: Exploring the status of retail private drug shops in Bangladesh and action points for developing an accredited drug shop model: a facility based cross-sectional study Journal of Pharmaceutical Policy and Practice 10: 21
Kammerer, W.S.; Pérez Esandi, M.V. 1973: Current status of drug therapy of hydatidosis Boletin de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau 75(6): 523-529
Beaird, S.L.; Coley, R.M.; Crea, K.A. 1992: Current status of drug information centers American Journal of Hospital Pharmacy 49(1): 103-106
Chodosh, A.; Korr, K.S.; Burtt, D. 2008: Status of drug-eluting coronary stents Medicine and Health Rhode Island 91(10): 309
Geursen, R. 1996: The drug industry and research: status in Germany Zentralblatt für Chirurgie 121(7): 603-605
Razani, J. 1977: Status of drug abuse and its treatment in Iran Addictive Diseases 3(1): 69-73
Cantore, M.; Raspadori, D.; Tazzari, P.L.; Monetti, N. 1986: Characterization of the immune status of 27 young drug addicts Giornale di Clinica Medica 67(1): 13-14; 19
Rabøl, R.; Kampmann, J.Peter.; Christensen, H.R. 2004: Drug committees in Denmark. Status and future challenges Ugeskrift for Laeger 166(35): 2988-2991
Bechtel, P. 1984: Drug surveillance. its present status, hopes for its future Gastroenterologie Clinique et Biologique 8(10): 702-703